INBX Inhibrx Biosciences, Inc.
Healthcare$106.85+5.46%ClosedMarket Cap: $1.57B
As of 2026-05-26
Insider Statistics (Q4 2025)
Acquisitions
0
Dispositions
3
Buy/Sell Ratio
0.00
Net Shares
-350,000
Shares Acquired
0
Shares Disposed
350,000
Total Bought ($)
$0.00
Total Sold ($)
$3.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon Apr 27 | Matly David | officer: President | Sell | 50,000 | $129.06 | 50,000 |
| Thu Oct 09 | VIKING GLOBAL INVESTORS LP | 10 percent owner | Sell | 308,643 | $32.25 | 1,267,823 |
| Thu Oct 09 | VIKING GLOBAL INVESTORS LP | 10 percent owner | Sell | 25,042 | $32.25 | 102,864 |
| Thu Oct 09 | VIKING GLOBAL INVESTORS LP | 10 percent owner | Sell | 16,315 | $32.25 | 67,018 |
| Thu May 29 | Vuori Kristiina MD | director | Sell | 15,000 | $12.91 | 15,000 |
| Thu May 29 | MANHARD KIMBERLY | director | Sell | 15,000 | $12.91 | 15,000 |
| Thu May 29 | Kayyem Jon Faiz | director | Sell | 15,000 | $12.91 | 15,000 |
| Thu May 29 | FORSYTH DOUGLAS | director | Sell | 15,000 | $12.91 | 15,000 |
| Wed Apr 02 | Matly David | officer: President | Sell | 50,000 | $14.05 | 50,000 |
| Wed Apr 02 | Matly David | officer: President | Sell | 175,000 | $15.86 | 0 |
| Wed Apr 02 | Deck Kelly | officer: Chief Financial Officer | Sell | 15,000 | $14.05 | 15,000 |